Michael S. Nakazawa
- Molecular Biology
- Cancer Research top 5%
- Oncology top 10%
- Pulmonary and Respiratory Medicine top 10%
- Cell Biology top 10%
- Co-authors
- M. Celeste SimonBrian KeithT.S. Karin Eisinger‐MathasonSam S. YoonNicolas SkuliVera MucajNavid SadriJessica E.S. Shay
- Topics
- Sarcoma Diagnosis and Treatment (8 papers)Cancer, Hypoxia, and Metabolism (6 papers)Vascular Tumors and Angiosarcomas (3 papers)
- Journals
- Proceedings of the National Academy of SciencesNature CommunicationsJournal of Clinical Oncology
- Partner nations
- United StatesFranceSlovakia
In The Last Decade
Michael S. Nakazawa
15 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 87
- Molecular Biology 649
- Cancer Research 539
- Oncology 340
- Pulmonary and Respiratory Medicine 271
- Cell Biology 142
Countries citing papers authored by Michael S. Nakazawa
This map shows the geographic impact of Michael S. Nakazawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael S. Nakazawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael S. Nakazawa more than expected).
Fields of papers citing papers by Michael S. Nakazawa
This network shows the impact of papers produced by Michael S. Nakazawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael S. Nakazawa. The network helps show where Michael S. Nakazawa may publish in the future.
Co-authorship network of co-authors of Michael S. Nakazawa
This figure shows the co-authorship network connecting the top 25 collaborators of Michael S. Nakazawa. A scholar is included among the top collaborators of Michael S. Nakazawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael S. Nakazawa. Michael S. Nakazawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 3 | |
| 4 | 0 | |
| 5 | 4 | |
| 6 | 5 | |
| 7 | 36 | |
| 8 | 58 | |
| 9 | 332 | |
| 10 | 35 | |
| 11 | 81 | |
| 12 | 53 | |
| 13 | 308 | |
| 14 | 213 | |
| 15 | 39 | |
| 16 | 4 | |
| 17 | 34 |
About Michael S. Nakazawa
Michael S. Nakazawa is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 17 papers that have together received 1.2k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (8 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Vascular Tumors and Angiosarcomas (3 papers). The work is most often cited by research in Cancer Research (539 citations), Oncology (340 citations) and Molecular Biology (649 citations). Michael S. Nakazawa has collaborated with scholars based in United States, France and Slovakia. Frequent co-authors include M. Celeste Simon, Brian Keith, T.S. Karin Eisinger‐Mathason, Sam S. Yoon, Nicolas Skuli, Vera Mucaj, Navid Sadri, Jessica E.S. Shay, John M. Maris and Giordano Caponigro. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.